Introduction
Androgens play an important role in human prostate carcinogenesis by binding to the androgen receptor (AR) of prostatic acinar cells and inducing transcription of target genes that promote neoplastic cell growth. 1 In antiandrogen therapy, anti-androgens compete with androgens for binding to the AR and thereby retard growth of hormone-sensitive prostate cancer (PCa) cells. Eventually, PCa reaches a hormone-refractory state, unresponsive to androgen deprivation, where AR is amplified or otherwise upregulated and becomes hypersensitive to remaining androgens or even to non-androgenic stimuli. 2 The AR thus transduces the androgen signal and plays a central role in hormone-sensitive and hormonerefractory PCa. 3 The AR gene (AR) is situated on the long arm of the X chromosome and produces a protein with N-terminal, DNA-and ligand-binding domains. A polymorphic-CAG repeat in exon 1, which in 95% of the population ranges in value from 16 to 29 repeats (with the majority having 20-24 repeats), encodes a polyglutamine tract within the amino-terminal domain. 4 Shortening of the polyglutamine tract has been related to increased transactivation of the AR. 5, 6 Recently, CAG repeat contraction within the AR has been implicated as a possible risk factor in prostate carcinogenesis. 4 Clinically, shortened CAG repeat lengths have been associated with increased risk of developing PCa, [7] [8] [9] [10] [11] differing racial predisposition for PCa, 7, 9, 11 increased clinical aggressiveness of the disease, 8 an early age at diagnosis 12 and as a possible prognostic factor in patients with metastatic disease. 13 These results are, however, controversial, as other studies have failed to support such correlations between AR CAG repeat length and PCa risk. 14, 15 The common denominator in all these studies is that only germline AR CAG repeat lengths in non-androgen-responsive tissues such as peripheral blood leukocytes were examined.
To clarify further the situation, we sought to examine the prostatic acinar cells themselves, rather than peripheral blood leukocytes. PCa is a multifocal, heterogeneous disease that arises predominantly in the peripheral, histo-anatomic zone of the prostate. The transitional and, in particular, the central zones (CZs) give rise to cancer much more rarely. 16 Indeed, the different zones show different proteomic profiles 17 that may be functionally important. The observed proclivity of PCa to develop in the peripheral zone (PZ) may be due to a differential growth advantage within PZ prostatic tissue.
In an initial study, we used laser capture microdissection (LCM) to dissect pathologically identified tissues from PCa tumors. When the ARs from microdissected samples of both cancerous and benign tissues were subsequently sequenced, it was found that the vast majority of the LCM samples contained a number of different AR CAG repeat lengths (somatic mosaicism), which showed a degree of repeat contraction. 18 In the present study, we have sought to obtain a better understanding of contraction of the CAG repeats in prostatic acinar cells by examining AR CAG repeat lengths in microdissected benign tissues and comparing them with the patient's germline DNA. In particular, we wished to determine if significant CAG repeat contractions arise in non-cancerous prostate tissues from different zones within diseased prostates. Further, we sought to assess the possible heterogeneity in AR protein expression that might accompany AR CAG repeat length changes.
Methods

Tissue processing
Benign PZ, transition zone (TZ) and CZ, PCa lesions and high-grade prostatic intraepithelial neoplasia (HGPIN) were mapped on whole-mounted radical prostatectomy specimens from 10 patients. In addition we were fortunate to obtain healthy prostates from six individuals ranging in age from 1 to 31 years. Tissue microarrays (TMA) were constructed from these regions using duplicate/triplicate 1 mm cores. Cells from the TMA sections were collected using LCM. Immunohistochemistry for AR was performed on a set of the replicate TMA preparations. Peripheral blood samples and matched prostate tissues (ca. 2500 cells isolated by LCM) were also analyzed from three additional patients using an equivalent amount of DNA. Leukocyte DNA was isolated, using the PURGENE DNA purification kit (Genta System Inc, Minneapolis, MN, USA), then amplified and sequenced in exactly the same manner as the LCM-prepared tissues. Informed consent was obtained from both the healthy individuals as well as all the patients, who ranged in age from 48 to 69, showed PSA values from 3.1 to 10.3, had PCa of Gleason scores 6/7 and pathologic stages pT2/3a (Table 1) .
LCM and DNA extraction
Histological sections were prepared from formalin-fixed, paraffin-embedded blocks and stained with hematoxylin and eosin (H&E) for histopathologic review. Under microscopic visualization, areas of interest on the section tissue were mapped for LCM. Microdissection of each area was performed using a PixCell II laser capture microscope (Arcturus Engineering, Santa Clara, CA, USA) following the manufacturers protocols. Approximately 2500 cells were microdissected each time from 5-mm-thick histological sections. DNA was extracted from LCM captured cells as described previously. 18 
PCR
Two rounds of polymerase chain reaction (PCR) using nested primers flanking the AR CAG repeat in exon 1 were performed. The primers used were: HotStarTaq DNA polymerase (Qiagen, Mississauga, ON, Canada) was used in combination with Q-solution for higher fidelity amplification of GC-rich templates. A 50 ml reaction mixture containing 5 ml of prepared DNA, 100 ng of primers 1.1A and 1.1B, 0.15 mM of each dNTP, 1 Â HotStarTaq amplification buffer, 1 Â Q-solution and 3.75 U of HotStarTaq DNA polymerase was used to amplify the CAG repeat by successive PCR rounds. The conditions for the first round of PCR were: 951C for 15 min, then 40 cycles (941C Â 30 s, 581C Â 45 s, 721C Â 45 s) and a final elongation at 721C for 5 min. The second PCR used 5 ml of the first PCR , primers 1.15A and 1.15B and the same reaction conditions as the first PCR. The number of PCR cycles is similar to that of a number of other studies where genes from microdissected tissues were sequenced. 19, 20 All the PCR were prepared in a PCR workstation to prevent contamination.
PCR products from the second round were electrophoresed in 2% agarose gels containing ethidium bromide. The bands of interest were excised from the gel and the DNA extracted and purified using the MinElute Gel Extraction kit (Qiagen).
Sequencing
The CAG repeat was sequenced using the ThermoSequenase Radiolabeled Terminator Cycle kit (GE Healthcare, Baie d'Urfé, QC). Samples were prepared following the manufacturers protocol and loaded into a sequencing gel prepared using a Gene-Gel 6% gel-casting solution (Bioshop Canada Inc, Burlington, Canada). Following electrophoresis, the gel was vacuum-dried and exposed to Kodak Biomax MR film (Eastman Kodak Company, Rochester, NY, USA) overnight at room temperature.
Immunohistochemistry
Immunohistochemistry was performed using standard avidin-biotin techniques with diaminobenzine as the chromogen. An automated immunostainer (Benchmark, Ventana Medical Systems, Tucson, AZ, USA) was used, with an antibody to the AR (Ab-1monoclonal 1:100; Lab 
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Vision, Fremont, CA, USA). A routine H&E stained section was also prepared.
Digital image analysis
Immunostained sections were photographed with an Olympus digital camera (Q Capture Pro version 5.0.1.26; QImaging Corporation, Burnaby, BC, Canada) at magnifications of Â 200 and Â 400 using identical settings for all captured images. Images were analyzed using BioQuant image analysis software (version 6.50.10; BioQuant Image Analysis Corporation, Nashville, TN, USA). 21 Thresholds set using positive staining of control sections were used to analyze all photographed images. Areas containing prostatic acinar cells of the pathologically defined lesions were traced and pixel counts of the immunoreaction's product were automatically generated by the software and reported as total optical density of the integrated immunostaining over a given area. This reflects the relative amount of AR within the traced area.
Results
CAG repeat length contractions in LCM-dissected tissues
The focus of this study was to explore AR CAG repeat length contraction within prostate tissues. To ensure that we were getting an accurate picture of the process, we examined microdissected benign prostate tissues from prostate tumors and in certain cases compared the results with AR CAG repeat lengths from matched samples from germline peripheral blood leukocytes. In addition, we sought to determine if genetic heterogeneity due to AR CAG repeat contraction is reflected at the level of AR protein expression by quantifying AR immunostaining in specific areas of prostate tissue that were replicates of the microdissected areas.
To establish the baseline data, we first examined histologically prepared prostate TMA samples from 13 PCa patients (Table 1) to assess the degree of contraction in AR CAG repeat length. This revealed varying degrees of repeat length contraction in the form of multiple shorter repeat lengths. Figure 1 exemplifies typical overall contractions by comparing CAG sequencing of LCM prostate samples with peripheral blood samples. Case A showed a number CAG repeat lengths of 13, 14, 16, 18, 19 and 20 (Figure 1b ). This genetic heterogeneity (somatic mosaicism) was typical of most LCM samples. Case E, on the other hand, was an exception, in that it only had one AR sequence, though with the most extreme form of contraction, as the CAG repeat length was zero ( Figure 1c) . As a control, DNA from peripheral blood leukocytes/lymphocytes was examined and each sample had only one CAG repeat length that was within the normal range, for example, 20 ( Figure 1a ). To ensure that these CAG repeat contractions were specific to prostate tissue, we compared CAG repeat lengths in prostate tissues and matched peripheral blood samples and in all cases where we analyzed matching peripheral blood samples only the prostate tissue showed CAG repeat contraction ( Table 2 ). The repeat contractions occur in the context of somatic mosaicism, so that the prostate tissue usually showed a number of different contracted lengths as illustrated in Figure 2 .
As our focus was to try to understand the significance of the CAG repeat contractions, we examined noncancerous prostate tissues in considerable detail and consistently observed AR CAG repeat length contractions in the PZ (Figure 3a) , (Figure 3b ) CZ and TZ (Figure 3c) regions. The present study also detected CAG repeat contractions in HGPIN (Figure 4a ) and PCa regions (Figure 4b ) within the same diseased prostates. Indeed, in patients A-J even non-cancerous regions had a number of zero repeat lengths, that is, the complete deletion of all AR CAG repeats (Table 3 ). The presence of contracted CAG repeat lengths in benign tissue from diseased prostates raised the question as to whether such contractions existed in normal nondiseased prostates. We were extremely fortunate to obtain healthy prostates from six individuals ranging in age from 1 to 31 years (Table 4 ). Much to our surprise, in every case more than one contracted CAG repeat length was found in the prostate LCM samples and all six nondiseased prostates examined had at least one AR with zero CAG repeats ( Figure 5 ).
In light of the novelty of these observations we have confronted a number of issues, including the possibility that the multiple contracted CAG repeat lengths observed was a PCR artefact. To validate our observations, we used simple plasmid DNA (AR cDNA) and several genomic DNA sources, for example, genital skin fibro- 22 The possibility of PCR contamination or that the large number of contracted CAG repeat lengths observed was an epiphenomenon due to the increase in growth and division of neoplastic tissues has already been addressed. 18 Another possible issue was that formalin fixation, which has been reported to induce PCR errors in the form of random-base substitutions, though not deletions, could have introduced artefacts. However, heterogeneous CAG repeat lengths always remained reproducible and a new set of repeat lengths was not produced when samples were reanalyzed. To further rule out any possible fixation artifacts, a direct comparison between non formalin-fixed fresh frozen tissues (n ¼ 3) and fixed paraffin (n ¼ 3) prostate specimens obtained using LCM and analyzed using the same PCR protocols was undertaken. No differences were observed between the two sets of tissues. They both displayed multiple CAG repeats and did so to the same degree (data not shown).
Immunohistochemistry
As our results indicated the presence of a significant number of contracted AR CAG repeat lengths, we wanted to know if these contracted ARs would have an effect on overall AR protein expression. Since AR CAG repeat length may have an effect on AR mRNA stability 23 and the AR can upregulate its own expression, 24 presumably overall AR protein expression can be non-homogeneous as well. We therefore wished to see if concomitant AR protein heterogeneity may accompany AR CAG repeat heterogeneity and so we tested for the presence of AR in pathologically different areas of the prostate using immunohistochemistry with an AR-specific antibody ( Figure 6 ). All samples exhibited variable staining intensity, likely reflecting the mixture of ARs with shortened polyglutamine tracts within the tissues. While a linear relationship between immunohistochemical staining of AR and AR expression has been established, 25, 26 a visual scoring of AR cannot accurately reflect the often-subtle variation in immunohistochemical-staining intensity. 27 Therefore, computerassisted image analysis, similar to that used by other investigators to measure AR immunostaining 21, 25, 27, 28 was used to quantify AR expression. This confirmed the variability in intensity of AR immunohistochemical staining as shown by scatter plots (Figure 7 ). This variation is particularly significant in samples from the same pathological zone of the same patient, as it would confirm that the contraction of the CAG repeats occurs in tissues pathologically identified as homogeneous. Note that as tissue fixation conditions were identical they could not artificially skew the results. The TMA sections were stained in a single batch to assure uniform immunostaining conditions and slides were photographed and analyzed under similar conditions.
Discussion
Our initial studies on AR CAG repeat length variation 18 and two other reports 29, 30 have described the presence of somatic mosaicism of AR CAG repeat lengths in prostate tumors. In these studies it was also reported that there was a contraction in the CAG repeat length. In the present study, we wished to explore the possible origin of these contractions by examining a much wider range of normal and non-diseased prostate tissues.
The presence of contracted AR CAG repeat lengths in prostates from benign regions of diseased prostates suggests that the process of the CAG repeat length contraction precedes the establishment of even precancerous tissues, such as HGPIN, and indeed may be a significant precancerous event. By examining different regions of diseased prostates we noted that the process of CAG repeat contraction was almost ubiquitous in prostate tissue, while matching peripheral blood leukocytes/lymphocytes did not show any obvious CAG repeat contraction. In this regard, we were fortunate to obtain non-diseased prostates from six individuals and in all cases a significant contraction of the CAG repeat was found. Further, it is interesting to note that in sequencing AR CAG repeats from hundreds of tissue samples, contraction has not been observed. 22 The combined data therefore suggest that perhaps contraction of the AR CAG repeat is specific only to certain androgenresponsive tissues such as the prostate.
An obvious question is whether any other CAGcontaining genes have also been observed to show somatic mosaicism and repeat length contraction within prostatic tissues, as this would suggest that general genomic instability might be a property of prostate tissues. Such analysis has been done already, albeit in an indirect fashion. Genomic instability has been studied in PCa and by analyzing many different regions of the genome containing repetitive DNA sequences that is, mono-, di-tri-or tetranucleotide repeats. Overall, approximately 5-10% of tumors demonstrated genomic instability, which in almost all cases corresponded to slight increases or decreases in specific repeat lengths. 31 Thus, overall genomic instability is probably not responsible for the AR CAG tract changes that we have found. Further, somatic AR CAG repeat length contractions have now been reported in both human colon cancer 32 and hepatocellular carcinomas 33 and in both cases they have not been associated with microsatellite instability.
We assessed AR expression within similar pathological lesions of the same patients using a combination of immunohistochemistry and computer-assisted digital image analysis. Our observation of AR protein heterogeneity seems to add to the functional significance of AR CAG/polyglutamine heterogeneity in that the different contracted CAG repeat lengths observed in the sequencing data were clearly associated with heterogeneous AR protein expression. This could be the result of both positive feedback or upregulation of AR on AR expression 24 and the possible effect of variable CAG repeat lengths on AR mRNA stability. 23 It therefore seems likely that our dual observations of CAG repeat length heterogeneity and AR protein heterogeneity may be linked and that CAG heterogeneity may account for the observed differences in AR expression.
While heterogeneous AR expression has previously been documented, it has only been shown when different pathological lesions, that is, benign prostatic hyperplasia vs carcinoma of high grade, have been compared, rather than within each of the different lesions. [34] [35] [36] [37] Recent work has focused on AR overexpression in hormonerefractory PCa where immunostaining for AR was more intense in tumors with amplification of the AR gene. 38 However, our patient cohort consisted entirely of hormone-sensitive PCas, for which AR amplification is not likely a contributory mechanism. PCa tumor morphological heterogeneity is well known and is usually expressed by the assignment of a pathologic Gleason score. The finding of AR CAG repeat length shortening and deletion within samples with a specific Gleason score coupled with heterogeneous AR protein expression, suggests the existence of histologically similar cancer cells with differing androgen responsiveness.
Of particular interest is how CAG repeat contractions might make prostate tissues more susceptible to carcinogenesis. It is well established that shorter CAG repeats confer increased AR transactivation activity 5 and this may have functional significance within the prostate gland by allowing for selection of cells that exhibit more androgen-dependent growth and are therefore perhaps more likely to become cancerous. Also, a recent study has shown that AR proteins containing shorter polyglutamine tracts responded to lower concentrations of androgens than the wild-type AR, 39 suggesting that cells AR CAG repeat contraction in prostate tissues K Sircar et al with shorter AR polyglutamine tracts are more likely to be preferentially selected for within androgen-responsive tissue. Such preferential selection may be an important factor in the conversion of PCa tissues into an androgeninsensitive state. A possible mechanism for achieving androgen independence has been suggested by a recent study of mutant ARs from human PCa tumors that showed a significant number of the mutant receptors were promiscuous, that is, were transactivated by nonandrogens. 40 It seems reasonable to believe that such mutations are more likely to be selected in genetically heterogeneous tissues that include ARs with shorter CAG repeat lengths, due to the ability of such tissues to grow more efficiently as a result of increased AR transactivational activity.
What is particularly striking is that when cancer rates are examined within androgen-responsive tissues the incidence in prostate tissues is by far the highest. It must be assumed therefore that there is something very different about prostate tissue compared with other androgen-responsive tissues and perhaps susceptibility of AR CAG repeats to contract is one of them.
The idea that a potential biomarker for PCa is also present in non-cancerous tissue surrounding cancerous tissue is clearly intriguing. Further, there now exists some evidence to support the observation that molecular alterations occur in non-cancerous tissues surrounding cancer foci in the prostate. In one study, Yu et al. 41 performed comprehensive gene expression analysis on PCa tissues, prostate tissues adjacent to cancer foci and organ donor prostates. They identified 1022 genes that were differentially expressed in prostate tissues adjacent to tumors compared with organ donor prostates. Most significant was that the expression of 70% of these genes was similarly altered in the tumor samples.
Finally, the observation of the presence of CAG repeat contractions in non-diseased prostates adds additional weight to the argument that perhaps prostate tissues have certain innate properties. In trying to understand how such contractions might arise a recent paper 42 demonstrated in a trinucleotide CAG repeat mouse model that the contraction process appeared to occur during replication, was limited to early embryonic development and did not occur in adult life. More AR CAG repeat contraction in prostate tissues K Sircar et al importantly control mice with 19 CAG repeats had a much higher proportion of CAG repeat contractions that was clearly limited to early embryonic development. Our observations are in keeping with these results, which are suggestive of an early embryonic phenomenon. In addition, recently, Lin et al. 43 demonstrated that induced transcription of CAG repeats increased large repeat CAG contractions by 15-fold with no evidence of expansions. These observations may therefore help explain why AR CAG repeat contractions are limited to the prostate as the prostate, almost uniquely expresses higher levels of AR, at an early stage of development.
To confirm these observations, further studies will be required to determine if the contraction of AR CAG repeats could be a reliable predictor of future carcinogenesis within prostate tissues.
